We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Sunitinib + Docetaxel as Second-line Treatment in Gastric Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01238055
Recruitment Status : Completed
First Posted : November 10, 2010
Last Update Posted : April 9, 2013
Sponsor:
Information provided by (Responsible Party):
Samsung Medical Center

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : April 2012
  Study Completion Date : October 2012